Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Future cancer treatment using antiparticles from the exotic “antiworld”

An international research team has taken the first, but nevertheless promising step towards a new form of radiotherapy for cancer. This team includes scientists at the Department of Physics and Astronomy, the University of Aarhus, as well as the Department of Medical Physics and the Department of Experimental Clinical Oncology, the Aarhus University Hospital.

In an experiment at CERN (the European Organization for Nuclear Research), located near Geneva, the scientists have demonstrated that a beam of antiprotons can destroy cancer cells considerably more effectively than the types of radiation used to date. In the long term, this can lead to a more effective and more gentle treatment for certain tumours.

The results have just been published in the renowned journal Radiotherapy and Oncology.

The mysterious antiparticles have been common knowledge for decades, but the scientists are the first to show the advantage of using antiprotons to destroy cancer cells. The new technique using antiparticles has a number of benefits:

A comparison of damage to the healthy tissue surrounding the tumour shows that antiproton beams destroy cancer cells much more effectively than the beams used to date. This is because the antiprotons have an effect that slightly resembles grenades. They cause most damage to the patient’s cells right at the target point – just as a grenade only explodes when it gets to the end of its trajectory.

Each individual patient therefore requires significantly fewer treatments.
Irradiating cancerous tissue can be carried out with a high degree of spatial precision because it is possible to hit a tumour within areas as small as one cubic millimetre.

An added advantage of antiproton treatment is that it makes it possible to continuously monitor exactly where the irradiation takes place.

Unfortunately, the promising results will first benefit the treatment system in ten years at the earliest. This is partly because producing antiprotons is expensive and requires setting up large, new accelerators specially designed for the purpose. Secondly, a long list of new measurements are required before clinical tests can begin. However, the important point is that the scientists have now proved the significant, positive effect of antiproton irradiation.

This new knowledge itself is an important radiobiological result because the scientists are the first to demonstrate the biological effect of antiprotons. The new knowledge can therefore be used immediately to increase our understanding of how antiparticle beams inactivate cancer cells. As far as the scientists are concerned, the basic scientific insight they have acquired into the biological effect of antiprotons is a major victory in itself, and one that paves the way towards much more cross-disciplinary research. The composition of the research team illustrates the importance placed on interdisciplinary collaboration, as it involves physicists, hospital physicists, doctors, microbiologists and other experts. In addition to the Danish scientists, the team consists of experts from the USA, Canada, Switzerland, the Netherlands and other countries.

The project is funded by the Danish Cancer Society and the Danish Agency for Science, Technology and Innovation.

Antiprotons do not belong to our world

An antiproton is a so-called antiparticle. It is thus part of the mirror world that also consists of the positron – the electron’s antiparticle – as well as other exotic particles. A common feature of them all is that they are not normally found in our world. However, antiprotons are produced in large accelerators at CERN, and have been used there to destroy cancer cells.

The special feature of antiprotons is that their speed can be adjusted so they penetrate the tumour without intruding any further into the patient, and thus cause no further tissue damage. The antiprotons find a normal proton inside the tumour, and this pair is converted to energy and other particles – some of which destroy cancer cells – in a disintegration process.

Dan Frederiksen | alfa
Further information:

More articles from Physics and Astronomy:

nachricht A new kind of quantum bits in two dimensions
19.03.2018 | Vienna University of Technology

nachricht 'Frequency combs' ID chemicals within the mid-infrared spectral region
16.03.2018 | American Institute of Physics

All articles from Physics and Astronomy >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

Im Focus: Surveying the Arctic: Tracking down carbon particles

Researchers embark on aerial campaign over Northeast Greenland

On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...

Im Focus: Unique Insights into the Antarctic Ice Shelf System

Data collected on ocean-ice interactions in the little-researched regions of the far south

The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...

Im Focus: ILA 2018: Laser alternative to hexavalent chromium coating

At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.

When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

A new kind of quantum bits in two dimensions

19.03.2018 | Physics and Astronomy

Scientists have a new way to gauge the growth of nanowires

19.03.2018 | Materials Sciences

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Science & Research
Overview of more VideoLinks >>>